Literature DB >> 10438364

The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.

F G Mackinnon1, Y Ho, M S Blake, F Michon, A Chandraker, M H Sayegh, L M Wetzler.   

Abstract

A T cell-dependent immune response to group C meningococcal capsular polysaccharide (CPS) can be elicited when CPS is conjugated to the class 3 neisserial porin (CPS-porin). Treatment of CPS-porin-immunized mice with B7-2 blocking monoclonal antibody (MAb) caused a dramatic reduction in the CPS-specific IgG response, treatment with anti-B7-1 MAb had no effect, and concurrent blockade of B7-1 and B7-2 resulted in a synergistic abrogation of the CPS-specific IgG response while the CPS IgM response was unaffected. Anti-CD40L MAb treatment caused a significant reduction of both CPS-specific IgG and IgM levels. In contrast, blockade of CTLA4 interactions resulted in increases in both CPS IgG and IgM responses in CPS-porin-immunized mice. These data support the hypothesis that the ability of neisserial porins to improve the immune response to poorly immunogenic antigens (e.g., polysaccharides) is related to porin-induced increases in B7-2 expression on antigen-presenting cells and enhanced B/T cell interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438364     DOI: 10.1086/314966

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Induction of cytokine mRNA expression in U937 cells by Salmonella typhimurium porins is regulated by different phosphorylation pathways.

Authors:  Marilena Galdiero; Annalisa Tortora; Nicola Damiano; Mariateresa Vitiello; Anna Longanella; Emilia Galdiero
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

2.  Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.

Authors:  N Bhasin; Y Ho; L M Wetzler
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity.

Authors:  Lee M Wetzler
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

4.  The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity.

Authors:  Deana N Toussi; Xiuping Liu; Paola Massari
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

5.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

7.  Crystallographic analysis of Neisseria meningitidis PorB extracellular loops potentially implicated in TLR2 recognition.

Authors:  Christof Kattner; Deana N Toussi; Jan Zaucha; Lee M Wetzler; Nadine Rüppel; Ulrich Zachariae; Paola Massari; Mikio Tanabe
Journal:  J Struct Biol       Date:  2013-12-19       Impact factor: 2.867

8.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 9.  Vaccines against tularemia.

Authors:  Eileen M Barry; Leah E Cole; Araceli E Santiago
Journal:  Hum Vaccin       Date:  2009-12-11

10.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.